Parnassus

Jeroen Roose, PhD studies Ras signaling and its impact on lineage decisions in stem cells and progenitor cells.

Carolyn Sangokoya MD, PhD is a physician-scientist, RNA biologist, and liver pathologist studying RNA and metabolic networks driving cell fate, function, and plasticity. Her lab builds and uses molecular tools to evaluate, re-engineer, and re-wire cell fates for targeted plasticity and regenerative medicine.

Richard Schneider, PhD studies the development of neural crest, a mesenchymal cell population, and its role in patterning of the craniofacial organization.

Licia Selleri, MD, PhD studies the genetic and regulatory control of cranial and appendicular morphogenesis in embryonic development, evolution and disease using different model and non-model organisms.

Neil Shah, MD, PhD is an expert in developing molecularly targeted therapies for chronic myeloid leukemia and other hematologic malignancies.

Yin Shen, PhD utilizes genomics tools to investigate the genetic and epigenetic contributions to gene regulation in development and diseases.

Julie Sneddon, PhD studies pancreatic development and type I diabetes, employing the tools of stem cell biology, developmental biology, genomics and tissue engineering.

Matthew Springer, PhD studies cell and gene therapies for ischemic diseases to aid in tissue revascularization, preservation and potentially regeneration. He also researches vascular endothelial function and its response to diet and cigarette smoke exposure.

Qizhi Tang, PhD is working on developing regulatory T cell therapies to induce immune tolerance so that foreign tissue can be transplanted without the need for life-long immunosuppression.

Thea Tlsty, PhD studies the identity and role of cancer stem cells in the development and progression of breast cancer. She also has a research program on the characterization of genomic instability in cancer initiation and progression.